Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial

NCT02867969 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT02867969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02867969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2016
Completion date
May 31, 2017
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinocerebellar ataxia